Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for <i>Helicobacter pylori</i> infection

Abstract

AIM: infection. METHODS: . RESULTS: > .99) analyses. Non-inferiority in the eradication success between PAMB and PBMT was confirmed. The amoxicillin-, metronidazole-, tetracycline-, clarithromycin-, and levofloxacin-resistance rates were 8.3, 40, 9.4, 23.5, and 42.2%, respectively. Antimicrobial resistance did not significantly affect the efficacy of either therapy. Overall compliance was 98.1%. Adverse events were not significantly different between the two therapies. CONCLUSION: infection in regions with high clarithromycin and metronidazole resistance.